Suppr超能文献

利用计算机数据库检测出的耐药性高血压和未确诊的原发性醛固酮增多症。

Resistant hypertension and undiagnosed primary hyperaldosteronism detected by use of a computerized database.

机构信息

VA Northern California Health Care System, Mather Field, CA 95655, USA.

出版信息

J Clin Hypertens (Greenwich). 2011 Jul;13(7):487-91. doi: 10.1111/j.1751-7176.2011.00443.x. Epub 2011 Mar 28.

Abstract

A pharmacy database was used to identify patients with resistant hypertension who could then be tested for the presence of primary hyperaldosteronism. Inclusion criteria were: (1) resistant hypertension defined as uncontrolled hypertension and use of 3 antihypertensive medication classes or ≥ 4 antihypertensive classes regardless of blood pressure; (2) low or normal potassium levels (≤ 4.9 mEq/L); and (3) continuous health care from October 1, 2008, to February 28, 2009. Exclusion criteria were: (1) past or current use of an aldosterone antagonist, or (2) a medication possession ratio (adherence) <80% for any antihypertensive drug. Hyperaldosteronism was classified as an aldosterone/renin ratio (ARR) ≥ 30. Using the computer, 746 patients were identified who met criteria. After manual chart review to verify inclusion and exclusion criteria, 333 patients remained. Of 184 individuals in whom an ARR was obtained, 39 (21.2%) had a ratio of ≥ 30. A computer database is useful to identify patients with resistant hypertension and those who may have primary aldosteronism.

摘要

使用药房数据库来识别患有耐药性高血压的患者,然后对这些患者进行原发性醛固酮增多症的检测。纳入标准为:(1)耐药性高血压定义为未控制的高血压和使用 3 种降压药物类别或≥ 4 种降压药物类别,无论血压如何;(2)低钾或正常钾水平(≤ 4.9 mEq/L);(3)从 2008 年 10 月 1 日至 2009 年 2 月 28 日期间持续接受医疗保健。排除标准为:(1)过去或目前使用醛固酮拮抗剂,或(2)任何降压药物的用药维持率(依从性)<80%。醛固酮增多症被定义为醛固酮/肾素比值(ARR)≥ 30。通过计算机,共确定了 746 名符合条件的患者。在进行手动图表审查以验证纳入和排除标准后,仍有 333 名患者符合条件。在获得 ARR 的 184 名个体中,有 39 名(21.2%)的比值≥ 30。计算机数据库可用于识别患有耐药性高血压的患者和可能患有原发性醛固酮增多症的患者。

相似文献

1
Resistant hypertension and undiagnosed primary hyperaldosteronism detected by use of a computerized database.
J Clin Hypertens (Greenwich). 2011 Jul;13(7):487-91. doi: 10.1111/j.1751-7176.2011.00443.x. Epub 2011 Mar 28.
5
Resistant hypertension and aldosteronism.
Curr Hypertens Rep. 2007 Nov;9(5):353-9. doi: 10.1007/s11906-007-0066-7.
6
7
Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
Hypertens Res. 2010 Aug;33(8):850-6. doi: 10.1038/hr.2010.76. Epub 2010 Jun 3.
8
A case of primary aldosteronism with a negative aldosterone-to-renin ratio.
BMC Cardiovasc Disord. 2021 Jul 22;21(1):350. doi: 10.1186/s12872-021-02162-8.
9
Prevalence of hyperaldosteronism in primary care patients with resistant hypertension.
J Am Board Fam Med. 2012 Jan-Feb;25(1):98-103. doi: 10.3122/jabfm.2012.01.110099.
10
Aldosteronism and hypertension.
Clin J Am Soc Nephrol. 2006 Sep;1(5):1039-45. doi: 10.2215/CJN.01060306. Epub 2006 Jul 12.

引用本文的文献

1
Exploring issues in difficult-to-treat hypertension.
J Clin Hypertens (Greenwich). 2013 Dec;15(12):859-64. doi: 10.1111/jch.12219. Epub 2013 Oct 30.

本文引用的文献

1
US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.
JAMA. 2010 May 26;303(20):2043-50. doi: 10.1001/jama.2010.650.
2
Aldosterone and arterial hypertension.
Nat Rev Endocrinol. 2010 Feb;6(2):83-93. doi: 10.1038/nrendo.2009.263. Epub 2009 Dec 22.
3
Screening for primary aldosteronism in a cohort of Brazilian patients with resistant hypertension.
J Clin Hypertens (Greenwich). 2008 Aug;10(8):619-23. doi: 10.1111/j.1751-7176.2008.08421.x.
4
Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline.
J Clin Endocrinol Metab. 2008 Sep;93(9):3266-81. doi: 10.1210/jc.2008-0104. Epub 2008 Jun 13.
6
Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing.
Clin Med (Lond). 2005 Jan-Feb;5(1):55-60. doi: 10.7861/clinmedicine.5-1-55.
8
Role for adrenal venous sampling in primary aldosteronism.
Surgery. 2004 Dec;136(6):1227-35. doi: 10.1016/j.surg.2004.06.051.
10
Would wider screening for primary aldosteronism give any health benefits?
Eur J Endocrinol. 2004 Sep;151(3):305-8. doi: 10.1530/eje.0.1510305.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验